Studies have demonstrated that Ang II inhibits insulin-mediated PI3K pathway activation, thereby impairing endothelial NO production and Glut-4 translocation in insulin-sensitive tissues, which results in vascular and systemic insulin resistance, respectively [46]. This evidence concerns the gene SLC2A4 and Insulin resistance.